Log in to your Inderes Free account to see all free content on this page.
AcuCort
0.68 SEK
-6.58 %
Less than 1K followers
ACUC
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for AcuCort
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 0.7 | 0.7 | |||||
| growth-% | 1.5 % | ||||||
| EBITDA | -8.4 | -7.7 | -11.3 | -14.8 | -13.3 | -17.4 | -18.3 |
| EBIT | -8.4 | -7.7 | -11.3 | -14.8 | -13.3 | -17.4 | -26.5 |
| Profit before taxes | -8.4 | -7.8 | -11.3 | -14.8 | -13.7 | -17.4 | -26.2 |
| Net income | -8.4 | -7.8 | -11.3 | -14.8 | -13.7 | -17.4 | -26.2 |
| EPS | -0.27 | -0.25 | -0.39 | -0.32 | -0.37 | -0.18 | -0.22 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % |
Login required
This content is only available for logged in users
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | -2,557.4 % | -2,658.0 % | |||||
| EBIT-% | -2,557.4 % | -3,839.1 % | |||||
| ROE | -15.5 % | -16.8 % | -18.8 % | -32.4 % | -28.8 % | -42.6 % | -41.1 % |
| ROI | -14.9 % | -16.4 % | -17.9 % | -29.8 % | -23.4 % | -38.4 % | -39.0 % |
Login required
This content is only available for logged in users